| Ms Jennifer Anne-song Vaughn, MS | |
|
617 Oak St, Brainerd, MN 56401-3610 | |
| (218) 851-5484 | |
| Not Available |
| Full Name | Ms Jennifer Anne-song Vaughn |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 617 Oak St, Brainerd, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710260708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2090 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer Anne-song Vaughn, MS 12756 Lakewood Ln, Baxter, MN 56425-7433 Ph: (218) 851-5484 | Ms Jennifer Anne-song Vaughn, MS 617 Oak St, Brainerd, MN 56401-3610 Ph: (218) 851-5484 |
News Archive
It is well known that survivors of breast cancer have a much higher risk of developing a second breast cancer than women in the general population have of developing a first breast cancer. However, little is known about what lifestyle factors may make survivors more vulnerable to a second cancer.
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment of the first patients in its ProForce Registry. The news marks the launch of the ProForce Registry Study, an international, single arm, multi-center, post-market trial of Endosense's TactiCath force-sensing ablation catheter.
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI).
Tumors can be damaging to surrounding blood vessels and tissues even if they're benign. If they're malignant, they're aggressive and sneaky, and often irrevocably damaging. In the latter case, early detection is key to treatment and recovery.
A new study appearing in the Journal of Bone and Joint Surgery found that administering tranexamic acid (TXA) both intravenously (IV) and injected at the surgical site (intra-articular administration, or IA) reduced blood loss by 37 percent, compared to IV alone, following total knee replacement (TKR).
› Verified 5 days ago
Jennifer L. Owens, M.S. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4706 Wilderness Ct Ste 101, Brainerd, MN 56401 Phone: 218-454-3995 | |
Lauren Joy Roos, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 617 Oak St, Brainerd, MN 56401 Phone: 218-829-7140 Fax: 218-829-7124 | |
Michelle Kimman, MS, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 520 Nw 5th St, Brainerd, MN 56401 Phone: 218-829-3235 | |
Megan Kay Mueller, MS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 520 Nw 5th St, Brainerd, MN 56401 Phone: 218-829-3235 Fax: 218-829-1368 | |
Susan Carol Brennan, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 18510 Highway 371 Suite D, Brainerd, MN 56401 Phone: 218-833-2012 | |
Miss Julia Elizabeth Davick, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 823 Maple St, Brainerd, MN 56401 Phone: 815-978-6514 Fax: 218-454-1024 |